Long Prehensile Protrusions Can Facilitate Cancer Cell Invasion through the Basement Membrane.

3D culture basement membrane cell protrusion collagen contractility cytoskeleton integrin invasion myosin II spheroid

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
18 10 2023
Historique:
received: 26 09 2023
revised: 13 10 2023
accepted: 16 10 2023
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

A basic process in cancer is the breaching of basement-membrane barriers to permit tissue invasion. Cancer cells can use proteases and physical mechanisms to produce initial holes in basement membranes, but how cells squeeze through this barrier into matrix environments is not well understood. We used a 3D invasion model consisting of cancer-cell spheroids encapsulated by a basement membrane and embedded in collagen to characterize the dynamic early steps in cancer-cell invasion across this barrier. We demonstrate that certain cancer cells extend exceptionally long (~30-100 μm) protrusions through basement membranes via actin and microtubule cytoskeletal function. These long protrusions use integrin adhesion and myosin II-based contractility to pull cells through the basement membrane for initial invasion. Concurrently, these long, organelle-rich protrusions pull surrounding collagen inward while propelling cancer cells outward through perforations in the basement-membrane barrier. These exceptionally long, contractile cellular protrusions can facilitate the breaching of the basement-membrane barrier as a first step in cancer metastasis.

Identifiants

pubmed: 37887318
pii: cells12202474
doi: 10.3390/cells12202474
pmc: PMC10605924
pii:
doi:

Substances chimiques

Collagen 9007-34-5
Actins 0

Banques de données

figshare
['10.6084/m9.figshare.24299866']

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Intramural NIH HHS
ID : ZIA DE000524
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DE000718
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DE000719
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIC DE000750
Pays : United States

Références

Curr Opin Cell Biol. 2011 Oct;23(5):589-96
pubmed: 21632231
Nat Commun. 2017 Oct 13;8(1):924
pubmed: 29030636
Nature. 2020 Jun;582(7811):253-258
pubmed: 32523119
Nat Commun. 2022 Feb 2;13(1):626
pubmed: 35110548
Nat Phys. 2020 Jan;16(1):101-108
pubmed: 32905405
Am J Pathol. 2011 Mar;178(3):1221-32
pubmed: 21356373
Dev Cell. 2021 Mar 22;56(6):826-841.e4
pubmed: 33705692
Exp Cell Res. 2013 Oct 1;319(16):2424-33
pubmed: 23830878
Angiogenesis. 2020 Aug;23(3):315-324
pubmed: 31997048
PLoS One. 2016 Jun 07;11(6):e0156442
pubmed: 27271249
Nat Rev Cancer. 2021 Sep;21(9):592-604
pubmed: 34239104
Cell. 2023 Apr 13;186(8):1564-1579
pubmed: 37059065
NPJ Breast Cancer. 2020 Sep 7;6:42
pubmed: 32964116
Cells. 2021 Aug 04;10(8):
pubmed: 34440749
Nat Rev Cancer. 2003 May;3(5):362-74
pubmed: 12724734
Curr Top Dev Biol. 2018;130:143-191
pubmed: 29853176
ACS Nano. 2017 Dec 26;11(12):12037-12048
pubmed: 29144730
J Cell Biol. 1999 Nov 29;147(5):1023-38
pubmed: 10579722
Curr Biol. 2017 Mar 20;27(6):R207-R211
pubmed: 28324731
Nat Cell Biol. 2007 Dec;9(12):1392-400
pubmed: 18037882
iScience. 2021 Jan 28;24(2):102113
pubmed: 33659878
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11432-11443
pubmed: 32381732
Nat Methods. 2016 Feb;13(2):171-6
pubmed: 26641311
Elife. 2020 Apr 30;9:
pubmed: 32352379
Front Cell Dev Biol. 2022 Jul 15;10:926394
pubmed: 35912094
J Clin Invest. 2014 Mar;124(3):1069-82
pubmed: 24487586
Nat Rev Cancer. 2023 Jan;23(1):25-42
pubmed: 36385560
J Cell Biol. 2020 Aug 3;219(8):
pubmed: 32479595
Science. 2002 Mar 29;295(5564):2387-92
pubmed: 11923519
Nat Rev Mol Cell Biol. 2023 Feb;24(2):86-106
pubmed: 36104625
Cell. 2011 Nov 23;147(5):992-1009
pubmed: 22118458
Adv Sci (Weinh). 2022 Aug;9(23):e2201248
pubmed: 35712768
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Biophys J. 2000 Jul;79(1):144-52
pubmed: 10866943
Biomed Pharmacother. 2017 Feb;86:221-231
pubmed: 28006747
Breast Cancer Res. 2016 Sep 20;18(1):91
pubmed: 27645219
Phys Biol. 2022 Nov 21;20(1):
pubmed: 36343366
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):14043-14048
pubmed: 27872289
Nat Commun. 2022 Oct 27;13(1):6409
pubmed: 36302921
Cancer Sci. 2008 Nov;99(11):2252-9
pubmed: 18795939
Curr Protoc Cell Biol. 2020 Jun;87(1):e105
pubmed: 32436628
Commun Biol. 2020 Jul 21;3(1):390
pubmed: 32694539
Gels. 2022 Sep 07;8(9):
pubmed: 36135279
Signal Transduct Target Ther. 2020 Mar 12;5(1):28
pubmed: 32296047
Biophys J. 2019 Feb 19;116(4):670-683
pubmed: 30709621
Dev Biol. 2014 Oct 15;394(2):197-205
pubmed: 25158168
J Biol Chem. 1997 May 9;272(19):12257-60
pubmed: 9139666
Cell Metab. 2021 Jul 6;33(7):1307-1321
pubmed: 33915111
J Biochem. 2020 Apr 1;167(4):347-355
pubmed: 31926018
Mol Oncol. 2017 Jan;11(1):5-27
pubmed: 28085224
Matrix Biol Plus. 2020 Jan 25;6-7:100026
pubmed: 33543024
J Bone Miner Res. 2001 Aug;16(8):1486-95
pubmed: 11499871
Nat Commun. 2018 Nov 30;9(1):5111
pubmed: 30504768
J Cell Biol. 2019 Aug 5;218(8):2456-2469
pubmed: 31315943
iScience. 2021 Oct 12;24(11):103252
pubmed: 34755092
J Biol Chem. 2000 Feb 4;275(5):3577-82
pubmed: 10652353
ACS Appl Mater Interfaces. 2016 Aug 31;8(34):21946-55
pubmed: 27128771
Tissue Eng Part A. 2021 Apr;27(7-8):454-466
pubmed: 33397202
Acta Biomater. 2019 Jan 15;84:280-292
pubmed: 30500449
Cancer Rep (Hoboken). 2019 Dec;2(6):e1213
pubmed: 32467880

Auteurs

Shayan S Nazari (SS)

Cell Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.

Andrew D Doyle (AD)

Cell Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.

Christopher K E Bleck (CKE)

Electron Microscopy Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Kenneth M Yamada (KM)

Cell Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH